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doi:10.1016/j.ejvs.2011.06.018Abstract The technique of subintimal angioplasty has been attempted on 200 consecutive
femoropopliteal artery occlusions of median (range) length 11 (2e37) cm. The principle of
the technique is to traverse the occlusion in the subintimal plane and recanalise by inflating
the angioplasty balloon within the subintimal space. The technical success rate was 159/200
(80%) and was not significantly different for occlusions <10 cm (81%, n Z 73), 11e20 cm
(83%, nZ 63) or >20 cm (68%, nZ 23), pZ 0.20. There were no deaths nor limb loss resulting
from the procedure. The median (range) ankle-brachial pressure index increased from 0.61
(0.21e1.0) preangioplasty to 0.90 (0.26e1.50) postangioplasty. The actuarial haemodynamic
patencies of technically successful procedures at 12 and 36 months were 71% and 58% respec-
tively, the symptomatic patencies were 73% and 61%. A multiple regression analysis showed
that smoking multiplied the risk of reocclusion by 2.70 (p < 0.001), each additional run-off
vessel reduced the risk by 0.54 (p < 0.001) and the risk increased by 1.73 (pZ 0.020) for every
10 cm of occlusion length. In conclusion, the technical success rate (80%) of subintimal angio-
plasty for femoropopliteal occlusions is unrelated to occlusion length and for all procedures,
including technical failures, cumulative symptomatic and haemodynamic patencies of 46
and 48% can be achieved at 3 years. The factors influencing long-term patency were smoking,
the number of calf run-off vessels and occlusion length.
ª 2011 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.ing of the European Society for Vascular Surgery, Barcelona, September 1993.
blished in Eur J Vasc Endovasc Surg 1994;8:148e55.
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We have previously described the technique of subintimal
angioplasty for femoropopliteal artery occlusions and
provided data on short-term patency (mean follow-up, 6
months) after 71 procedures.1 The purpose of this paper is to
describe our continuing experience and to review the long-
term results of our first 200 consecutive attempted sub-
intimal angioplasties of femoropopliteal artery occlusions.Patients and MethodsFigure 1 Showing injection of dilute contrast to confirm the
subintimal location (a) of the catheter. The adjacent femoral
vein (v) is often outlined with contrast during this procedure,
presumably via venae comitantes.
Figure 2 Endovascular ultasonography after completion of
subintimal angioplasty of the right superficial femoral artery.
The ultrasound probe is lying within the subintimal space (S),
with the compressed true lumen (T) displaced laterally. The
femoral vein (V) lies medially.Patients and technique of subintimal angioplasty
Patients undergoing subintimal angioplasty of femo-
ropopliteal artery occlusions during the 64-month period
January 1987 to April 1992 were prospectively studied. All
procedures were performed by a single Vascular Radiologist
(A.B.). The contraindications to subintimal angioplasty
were acute thrombotic or embolic occlusions, the absence
of a femoral artery "stump" (at least 0.5 cm) and extension
of the occlusion below the infrageniculate popliteal artery.
The technique for subintimal angioplasty has undergone
minor modifications since the original description.1 After
diagnostic arteriography, the ipsilateral common femoral
artery is punctured and a size 5F (Van Andel type, Cook Ltd,
Letchworth, U.K.) predilating catheter introduced ante-
gradely up to the origin of the occlusion. Heparin (5000
units) and tolazoline (12.5 mg) are injected into the artery
and a straight floppy guidewire (3 cm floppy, 150 cm long,
0.035 inch diameter; Meadox, Dunstable, U.K.) used to
enter the occlusion. The tip of the wire is then directed
towards the arterial wall and the subintimal space inten-
tionally entered, taking care to avoid large collaterals. The
wire/catheter combination is then advanced into the
occlusion. Entry into the subintimar space is confirmed by
injection of a small volume of dilute contrast medium
(Fig. 1) and in addition the guidewire moves freely when
the subintimal space has been entered. The straight
guidewire is now replaced by a taper-tip J-wire (1.5 mm
taper, 150 cm long, 0.035 inch diameter; Meadox). The
occlusion is traversed either by forward pressure on the
J-wire itself or by advancing the catheter with the J-wire
protruding from it. When the catheter tip is 2e3 cm from
the distal end of the occlusion, the J-wire is manipulated to
form a large loop and the true arterial lumen re-entered by
forward pressure on the loop. The Van Andel catheter is
then replaced with a size 5F balloon catheter (Optiplast,
Toronto, Canada) and the balloon (usually 5 or 6 mm
diameter) inflated throughout the entire length of the
subintimal passage at 10e12 atmospheres for 15 seconds
(Figs. 2 and 3). If there is a residual stenosis of >30% then
the dilatation is repeated using slightly higher pressures. All
patients received a further intraarterial injection of tola-
zoline (12.5 mg) at the conclusion of the procedure. There
was no defined policy concerning aspirin administration
during the period of this study and those patients who were
prescribed postangioplasty aspirin received a daily dose of
150 or 300 mg. Oral anticoagulants were not prescribed
after the angioplasty procedure.Definitions and data analysis
Success, failure, complications and long-term patency were
analysed according to the guidelines provided by the
Figure 3 Showing a 25 cm superficial femoral artery occlu-
sion before (a) and after (b) subintimal angioplasty. The
smooth-walled ‘spiral ribbon’ appearance is characteristic of
subintimal angioplasty.
Table 1 Details of all patients and those patients in whom
subintimal angioplasty was technically successful.
All
patients
Technically
successful patients
Number of patients 176 145
Median (range)
age, yr
68 (22e92) 68 (22e92)
Males 130 (74) 108 (75)
Diabetes 33 (19) 26 (18)
Hypertension 62 (35) 48 (33)
Smokinga 61 (35) 57 (40)
Figures in parentheses are percentages.
a Refers to continued smoking after the angioplasty
procedure.
Subintimal Angioplasty S11Society of Vascular Surgery (SVS) and the International
Society for Cardiovascular Surgery (ISCVS).2e4 Technical
success was defined as recanalisation with 30% or less
residual stenosis and antegrade flow at the conclusion of
the procedure. Technical failures resulted from inability to
either enter, traverse or exit the subintimal space. Major
complications were defined as those that altered the
patient’s clinical state, whereas minor complications did
not. Patient follow up consisted of clinicial examination
and ankle-brachial pressure indices (ABPI) only. These were
performed at 24 h, 1, 3, 6, 9, 12 months and thereafter at 6-
monthly intervals. Patency was analysed by looking at
primary patency only, and the factors influencing reocclu-
sion were examined by investigating their effect on the
haemodynamic patency of technically successful proce-
dures. Haemodynamic patency required that the ABPI rose
by >0.10 within 24h and did not fall more than 0.15 from
the post-procedure level. Symptomatic patency required
that claudication distance improved by at least 50%, the
resolution of rest pain or healing of ulcers and minor
amputations. Peripheral run-off was documented by
examining arteriograms of the entire calf and classified as0-1 artery patent, 2 arteries patent or 3 arteries patent. We
used the definition of critical ischaemia suggested by the
Second European Consensus Document on Chronic Critical
Leg Ischaemia5 (rest pain for >2 weeks or ulceration or
gangrene at the foot plus an ankle systolic pressure less
than or equal to 50 mmHg).
Discrete variables were analysed with the Pearson chi-
squared test with Yates’ correction when the expected
number of observations was small. Continuous variables
were analysed by the ManneWhitney U test. Patency was
computed (Systat Survival package; Systat, London, U.K.)
using the KaplaneMeier method of life table analysis6 and
standard error calculations performed using the Greenwood
formula.7 Patients who died were censored at their last
follow-up visit, no patients were lost to follow-up during
the study. The minimum follow-up was 3 months, the
maximum 60 months. The effect of variables on the hae-
modynamic patency of the technically successful proce-
dures was compared in an univariate analysis with the
Mantel-Haenszel log-rank test.8 The variables examined in
the univariate analysis were; gender, diabetes, hyperten-
sion, aspirin ingestion, smoking, clinical presentation,
occlusion site, number of patent run-off arteries and
occlusion length. Multivariate analysis of the technically
successful procedures was performed using the Cox
proportional hazards model9 to analyse the effects of the
covariates. A stepwise selection of the covariates was
performed using the covariates significant at the 0.05 level
on univariate analysis. Risk multipliers and 95% confidence
intervals (CI) were computed using the same model. All
statistical tests were two-sided and p values of 0.05 or less
were considered significant.Results
Patient and procedure details
During the 64-month study period, 176 patients underwent
200 attempted subintimal angioplasty procedures for fem-
oropopliteal occlusive disease. During the same time period
a total of 987 lower limb angioplasty procedures were
performed on 831 patients, and 47 conventional intra-
luminal angioplasties were performed for femoropopliteal
Figure 4 Cumulative haemodynamic ( ) and symptomatic
patencies ( ) for all 200 attempted subintimal angioplasties
(i.e. analysed on an intention-to-treat basis).
Figure 5 Cumulative haemodynamic ( ) and symptomatic
patencies ( ) of the 159 technically successful procedures.
Table 2 Details of the technically successful and failed
procedures (total Z 200).
Successful Failures
Number 159 (80) 41 (20)
Diabetesa 28 (18) 9 (22)
Hypertension 57 (36) 18 (44)
Aspirinb 112 (70) 15 (37)
Smokingb 61 (38) 9 (22)
Critical ischaemiaa 18 (11) 4 (10)
Site of occlusiona
Femoral artery 120 (75) 34 (83)
Popliteal artery 39 (25) 7 (17)
Run-off
0-1 arteries patent 41 (26) 12 (29)
2 arteries patent 62 (39) 15 (37)
3 arteries patent 56 (35) 14 (34)
Occlusion lengtha
<10 cm 73(46) 17 (41)
10e20 cm 63 (40) 13 (32)
>20 cm 23 (14) 11 (27)
Occlusion length,a cm
median (range) 11 (2e30) 12 (2e37)
ABPI, median (range)
Pre-angioplasty 0.61
(0.21e1.00)
0.62
(0.23e0.76)
Post-angioplasty (24 h) 0.90
(0.26e1.50)
0.62
(0.31e0.81)
Figures in parentheses are percentages. ABPI: ankle-brachial
pressure index.
a The values for these variables are not significantly different
between the technically successful and failed groups.
b Refers to continued smoking or aspirin ingestion after the
angioplasty procedure.
S12 N.J.M. London et al.artery occlusions. Thus, the 200 subintimal angioplasties
reported here represent 20% of all lower limb angioplasties
and 81% of angioplasties for femoropopliteal artery occlu-
sive disease. Details of all patients (176) and those patients
in whom the angioplasty was technically successful (145)
are given in Table 1. Details of the technically successful
(159) and failed procedures (41) are given in Table 2. The
difference between the number of technically successful
patients (145) and procedures (159) arises because 14
patients underwent subintimal angioplasties on both limbs.
Because none of these bilateral procedures were concur-
rent, and because the analysis considers only primary
patency and does not consider repeat procedures on reoc-
cluded angioplasty segments (secondary patency), 30-day
mortality and patency calculations are based on the
number of procedures performed, not the number of
patients.
Technical success rate and complications
The technical success rate was 80% (159/200) and there
were no significant differences between the technical
success and failure groups with respect to the incidence of
diabetes, critical ischaemia/claudi- cation, occlusion site
or occlusion length (Table 2).The technical success rate for
occlusions <10 cm was 81%, for occlusions 11e20 cm was83% and for occlusions >20 cm was 68%, p Z 0.20. There
were two major (1%) and 13 minor complications (6.5%).
The major complications were one retroperitoneal and one
scrotal haematoma, and although both required surgical
evacuation, there were no long-term sequelae. The minor
complications were two groin haematomas, seven distal
emboli and four vessel perforations. The groin haematomas
resolved spontaneously. Two of the perforations required
no treatment, and two were treated by embolisation using
a 5F curved-tip non-tapered catheter and 3 mm diameter
1 cm long stainless steel spring coils (W. Cook, Bjaeverskov,
Denmark). Of the seven distal emboli, six were aspirated
using an 8F non-tapered aspiration catheter (W. Cook) and
in addition one required regional fibrinolysis with strepto-
kinase (5000 units/h) for 24 h. There were no deaths or limb
Table 3 Results of univariate analysis of variables influencing the long-term haemodynamic patency of technically successful
procedures.
Variable 12-month patency (%) Standard error of mean (%) Number at risk p valuea
Gender
male 72 5 63
female 68 8 19 0.423
Diabetes
present 61 10 13
absent 73 4 69 0.063
Hypertension
present 63 7 27
absent 76 5 55 0.201
Aspirin
prescribed 75 5 60
not prescribed 62 7 22 0.031
Smoking
smokers 61 7 24
non-smokers 77 5 58 0.001
Presentation
claudication 73 4 71
critical
ischaemia
60 12 11 0.144
Occlusion site
femoral 73 4 62
popliteal 66 8 20 0.413
Run-off arteries
0-1 patent 56 9 14
2 patent 67 7 32
3 patent 85 6 36 0.014
Occlusion length
<10 cm 77 5 46
10e20 cm 71 6 36
>20 cm 56 12 10 0.048
a Mantel-Haenszel log-rank test.
Subintimal Angioplasty S13loss directly related to the subintimal angioplasty proce-
dure. The 30-day mortality was 3/200 (1.5%), all three
deaths resulting from myocardial infarction.Patency
The long-term symptomatic and haemodynamic patencies
of all 200 procedures (i.e. analysed on an intention-to-treat
basis) and of the 159 technically successful procedures are
shown in Figs. 4 and 5 respectively. The haemodynamic
patencies at 12 and 36 months for all procedures were 56
and 46% respectively, the symptomatic patencies were 58
and 48%. The haemodynamic patencies at 12 and 36 months
for technically successful procedures were 71 and 58%Table 4 Results of the Cox model for proportional hazards.
Variable Estimated
Smoking (smoking vs. non-smoking) 2.70
Run-off (risk per run-off artery) 0.54
Occlusion length (risk per 10 cm occlusion) 1.73
The variables entered into the model were aspirin ingestion, smokingrespectively, the symptomatic patencies were 73 and 61%.
Five (3%) of the technically successful procedures failed
within 24 h. The results of the univariate analysis of factors
influencing patency of the technically successful proce-
dures are given in Table 3. The significant variables at the
5% level were aspirin ingestion, smoking, number of patent
run-off arteries and occlusion length. These covariates
were entered stepwise into the Cox proportional hazards
model and the results of this analysis are given in Table 4. It
can be seen that smoking is estimated to increase the risk
of reocclusion by a factor 2.70, each run-off artery reduces
the risk by a factor of 0.54 and each 10 cm of occlusion
length increases the risk by a factor of 1.73. Although
aspirin was significant in the univariate analysis, this effect
is lost in the multivariate model.risk multiplier 95% confidence interval p value
1.50e4.18 0.001
0.37e0.85 0.001
1.10e2.25 0.020
, number of patent run-off vessels and occlusion length.
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During our early experience,1 subintimal angioplasty was
only performed if the guidewire entered the subintimal
space accidentally. In recent years however, the subintimal
space has been deliberately entered with the intention of
performing subintimal recanalisation. Thus, although
throughout the total duration of the study, 81% of angio-
plasties for femoropopliteal artery occlusions were sub-
intimal, by the last two years of the study this figure had
risen to 95%. Indeed, intraluminal angioplasty is now only
used for very short (<2 cm length) occlusions, recent
occlusions, or occlusions of very small femoropopliteal
arteries (<4 mm diameter).
Although it is standard teaching that inadvertent sub-
intimal dissection during conventional intraluminal angio-
plasty is an indication to withdraw and relocate the guide-
wire or even abandon the procedure,10 there are theoret-
ical reasons why subintimal angioplasty might be advanta-
geous. The subintimal lane is the path of least resistance10
and surgeons who perform endarterectomy are familiar
with the ease with which occluding atheroma can be
excised in this plane. During subintimal angioplasty the
occlusion is traversed in an extraluminal plane and this may
explain why we found the technical success rate to be the
same for long and short occlusions. Recanalisation in the
subintimal plane can be likened to the situation in acute
aortic dissection where the dissection either re-enters the
true lumen spontaneously or is surgically fenestrated.11 In
this situation the false lumen is often larger and has
a higher blood flow than the true lumen.
Another potential advantage of subintimal angioplasty is
that thrombogenic, crushed atheroma, is displaced to one
side of the new lumen, whereas in conventional intra-
luminal angioplasty the new lumen is entirely surrounded
by thrombogenic material. A further theoretical advantage
of subintimal angioplasty is that unlike rotary atherectomy
or laser angioplasty, which use thermal, photoablative or
mechanical injury to traverse the occluded lumen, the
occlusion is traversed with minimal injury. This reduced
injury might be expected to minimise the restenosis rate
after angioplasty.12 A potential complication of subintimal
angioplasty is damage to collateral or main vessels distal to
the occlusion if these may be included in the dissected
portion. It is crucially important therefore that the
dissection is not extended too far distal to the occlusion.
Because of widely differing patient and lesion charac-
teristics, it is difficult to make meaningful comparisons
between the results of the present study and other studies
reporting the outcome of percutaneous transluminal
angioplasty for femoropopliteal artery occlusions.13e15
Published technical success rates vary from 26-91%.16e20
Our technical success rate of 83% for occlusions of
10e20 cm length compares favourably with the figure of
67% reported by Lammer et al.19 who used intraluminal
angioplasty for occlusions of a similar length. Comparisons
of long-term patency are also limited by the restrictions
mentioned above and published 1-year patencies range
from 25-73%.13,21 Our 12-month haemodynamic patency
(ABPI) of 71% for technically successful procedures
compares favourably with the figure of 38% afterintraluminal angioplasty reported by Lammer et al.19 It
should be noted that the longest occlusion treated in the
latter study was 19 cm, whereas in the present study 14%
of occlusions were >20 cm. Our finding that symptomatic
patencies were slightly greater than haemodynamic
patencies is in agreement with the results of other
studies19 and presumably reflects the development of
collateral vessels in some patients.4 The finding that the
number of run-off vessels and occlusion length signifi-
cantly influenced patency is not surprising and is in
agreement with the results of previous studies of intra-
luminal angioplasty.16,17,21,22 We found that smoking
profoundly reduced patency after subintimal angioplasty
and this underlines the importance of abstention in this
group of patients.
Our 1% major complication rate is in keeping with
reports of the complication rates after conventional intra-
luminal angioplasty.13 The most serious complication we
encountered was retroperitoneal haemorrhage after a high
groin puncture. However, this complication is not specific
to subintimal angioplasty and its potential dangers after all
forms of vascular investigation and intervention through
the common femoral artery have recently been
highlighted.23,24
On the basis of the data presented in this paper, we
conclude that subintimal angioplasty of femoropopliteal
artery occlusions can be performed with a high technical
success rate (80%) and a low major complication rate (1%).
The haemodynamic patencies of technically successful
procedures at 12 and 36 months were 71 and 58% respec-
tively and although it is not possible to make strict
comparisons with other studies, these results compare
favourably with the published results of other forms of
angioplasty. The specific advantages offered by subintimal
angioplasty are that it does not require specialised equip-
ment and is thus relatively cheap, it is not a technically
difficult procedure, and it is relatively non-traumatic.
Finally, although conventional teaching dictates that sub-
intimal dissection should be avoided, it should be remem-
bered that extensive subintimal dissection is frequently
seen even after conventional intraluminal angioplasty.25,26
We suggest therefore, that if the subintimal space is inad-
vertently entered during intraluminal angioplasty (as occurs
in roughly 25% of cases)19 that subintimal angioplasty is an
excellent alternative to repositioning the guide-wire or
abandoning the procedure. It is not known whether sub-
intimal angioplasty is preferable to intraluminal angioplasty
as a deliberate primary procedure and we have therefore
recently begun a randomised prospective study to investi-
gate this issue.References
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